Načítá se...

Initial Solid Tumor Testing (Stage 1) of AZD1480, an Inhibitor of Janus Kinases 1 and 2 by the Pediatric Preclinical Testing Program

BACKGROUND: AZD1480 is an ATP competitive inhibitor of Janus kinases 1 and 2 (JAK1, 2) that has been shown to inhibit the growth of solid tumor models. This agent was selected for testing the putative role of JAK/STAT signaling in the standard PPTP solid tumor models. PROCEDURES: AZD1480 was tested...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Houghton, Peter J., Kurmasheva, Raushan T., Lyalin, Dmitry, Maris, John M., Kolb, E. Anders, Gorlick, Richard, Reynolds, C. Patrick, Kang, Min H., Keir, Stephen T., Wu, Jianrong, Smith, Malcolm A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201390/
https://ncbi.nlm.nih.gov/pubmed/25131802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25175
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!